SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-13-002097
Filing Date
2013-11-14
Accepted
2013-11-14 15:53:31
Documents
3
Period of Report
2013-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e611547_8k-retrophin.htm 8-K 23106
2 e611547_ex99-1.htm EX-99.1 11016
3 GRAPHIC logo.jpg GRAPHIC 2697
  Complete submission text file 0001193805-13-002097.txt   39261
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 000-53293 | Film No.: 131219779
SIC: 2834 Pharmaceutical Preparations